Study of the Central and Peripheral Autonomic Function in Short Evolutions Type 2 Diabetes and it’s Risk Categories
DOI:
https://doi.org/10.17140/DROJ-1-103Abstract
Objective: Early detection of Diabetic Autonomic Neuropathy (DAN) could help prevent serious complications and mortality associated with this condition in type 2 diabetes. We aimed to determine the prevalence of Sudomotor Autonomic Dysfunction, Cardiac Autonomic Dysfunction (SAD, CAD) in the early stages of glucose metabolism alterations, ranging from risk categories for type 2 diabetes (prediabetes) to recently established type 2 diabetes. Research Design and Methods: It is a longitudinal, prospective and observational study (population consisting in 30 control subjects, 30 patients with increased risk for type 2 diabetes and 30 patients with type 2 diabetes ≤8 years of evolution. Study was carried out by designing a modified battery of Ewing. To study autonomic: resting Heart Rate (HR), deep inspiration, controlled breathing, 30/15, Valsalva maneuver, Sustained handgrip test (SHGT) and prolonged QTc indexes) and to study sudomotor: measurement of the Skin Conductance Response (SCR) deep inspiration, controlled breathing, standing to orthostasis, Valsalva maneuver and SHGT. The ECG and the Electrodermal response signal (EDR) was recorded while the patients execute the tests. Results: Results were statistically analyzed by taking into account the group the patients belonged to, their anthropometric variables (directly measured) and their results from blood tests. Obtained results allowed us to determine the order in which every autonomic index passes from normal to abnormal and the corresponding nerve fibers involved. Cardiac autonomic variables: resting HR: it is average value increases as the dysglicaemia progressed, significant differences were only found between the control and the type 2 diabetes group (p=0.041). Deep inspiration index: significant differences were only found between the increased risk group and the type 2 diabetes group (p=0.047). 42.9% of the control subjects, 39.1% of the increased risk patients and 59.3% of type 2 diabetes presented anomalous values for this index.
References
American Diabetes Association. Standards of Medical Care in Diabetes 2009. Diabetes Care. 2009; 32(1): S13-S61. doi: 10.2337/dc09-S013
Romero Maestre JC. Recent advances in cardiovascular auto-nomic neuropathy of diabetes mellitus. Rev Cubana Endocrinol. 1998; 9(2): 149-163.
Durruty P, García de los Ríos M. Glucotoxicity and lipotoxic-ity: factors in the pathogenesis and progression of diabetes type 2. Rev Méd Chile. 2001; 129: 671-679.
Lehtinen JM, Niskanen L, Hyvonen K, Siitonen O, Uusitupa M. Nerve function and its determinants in patients with newly-diagnosed type 2(non-insulin-dependent) diabetes mellitus and in control subjects: a 5-year follow-up. Diabetologia. 1993; 36: 68-72. doi: 10.1007/BF00399096
Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW. Risks for sensorimotor peripheral neuropathy and autonomic neu-ropathy in Non-Insulin-Dependent Diabetes Mellitus(NIDDM). Muscle Nerve. 1998; 21(1): 72-80. doi: 10.1002/(SICI)1097- 4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2
Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, Wahl PW. Prevalence of complications among second-gen-eration Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes. 1987; 36: 730- 739. doi: 10.2337/diab.36.6.730
Novella SP, Inzucchi SE, Goldstein JM. The frequency of un-diagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve. 2001; 24: 1229-1231. doi: 10.1002/mus.1137
Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care. 2001; 24: 1448-1453. doi: 10.2337/ diacare.24.8.1448
Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glu-cose tolerance. Neurology. 2003; 60: 108-111. doi: 10.1212/ WNL.60.1.108
Cappellari A, Airaghi L, Capra R, et al. Early peripheral nerve abnormalities in impaired glucose tolerance. Electromyo-gr Clin Neurophysiol. 2005; 45: 241-244.
Grandinetti A, Chow DC, Sletten DM, et al. Impaired glu-cose tolerance is associated with postganglionic sudomotor im-pairment. Clin Auton Res. 2007; 17(4): 231-233. doi: 10.1007/ s10286-007-0426-z
Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014; 126: 63-79. doi: 10.1016/B978-0-444-53480- 4.00006-0
Pop-Busui R. Cardiac autonomic neuropathy in diabetes, a clinical perspective. Diabetes Care. 2010; 33(2): 434-441. doi: 10.2337/dc09-1294
Gerritsen J, Dekker JM, TenVoorder BJ, et al. Glucose toler-ance and other determinants of cardiovascular autonomic func-tion: the Hoorn Study. Diabetologia. 2000; 43(5): 561-570. doi: 10.1007/s001250051344
Wu J-S, Yang Y-C, Lin T-S, et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab. 2007; 92: 3885-3889. doi: http://dx.doi. org/10.1210/jc.2006-2175
Watkins PJ, Edmonds ME. Sympathetic nerve failure in diabetes. Diabetologia. 1983; 25(2): 73-77. doi: 10.1007/ BF00250890
Takebayashi K, Aso Y, Sugita R, Takemura Y, Inukai T. Rela-tionship between sympathetic skin response and power spectral analysis of heart rate variation in patients with type 2 diabetes. Journal of Diabetes and Its Complications. 2004; 18(4): 224- 228. doi: 10.1016/S1056-8727(03)00090-4
Isak B, Oflazoglu B, Tanridag T, Yitmen I, Us O. Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev. 2008; 24: 563-569. doi: 10.1002/dmrr.859
Putz Z, Tabák AG, Tóth N, et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care. 2009; 32(1): 181-183. doi: 10.2337/dc08-1406
Karamitsos DT, Didangelos TP, Athyros VG, Kontopoulos AG. The natural history of recently diagnosed autonomic neu-ropathy over a period of 2 years. Diabetes Res Clin Pract. 1998; 42: 55-63. doi: 10.1016/S0168-8227(98)00089-8
Aso Y, Fujiwara Y, Inukai T, Takemura Y. Power spectral analysis of heart rate variation in diabetic patients with neuro-pathic foot ulceration. Diabetes Care. 1998; 21(7): 1173-1177.
Christie MJ. Electrodermal activity in the 1980s: a review. J R Soc Med. 1991; 74(8): 616¬622.
Jabbari A, Grimnes S, Martinsen OG. Electrodermal response correlation between potential and conductance. 13th Internation-al conference on electrical bioimpedance and the 8th conference on electrical impedance tomography 2007. IFMBE Proceedings. 2007; 17: 747-750. doi: 10.1007/978-3-540-73841-1_193
Winterhalter M, Schiller J, Münte S, et al. Prospective in-vestigation into the influence of various stressors on skin imped-ance. J Clin Monit Comput. 2008; 22(1): 67-74. doi: 10.1007/ s10877-007-9107-7
Gulbandilar E, Cimbiz A, Sari M, Ozden H. Relationship be-tween skin resistance level and static balance in type II diabetic subjects. Diabetes Res Clin Pract. 2008; 82(3): 335-339. doi: 10.1016/j.diabres.2008.09.011
Macleod AF, Smith SA, Cowell T, Richardson PR, Sonksen PH. Non-cardiac autonomic tests in diabetes: use of the galvanic skin response. Diabet Med. 1991; 8: S67-S70. doi: 10.1111/ j.1464-5491.1991.tb02160.x
Gæde P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with Type 2 diabetes and microalbuminuria: the Steno Type 2 randomised study. Lancet. 1999; 353: 617-622. doi: 10.1016/s0140-6736(98)07368-1
Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin(Barc). 2001; 117(14): 530-533.
Martinez JP, Almeida R, Olmos S, Rocha AP, Laguna P. A wavelet-based ECG delineator: evaluation on standard databas-es. IEEE Transactions on Biomedical Engineering. 2004; 51(4): 570-581. doi: 10.1109/TBME.2003.821031
Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropa-thies: a statement by the American Diabetes Association. Diabe-tes Care. 2005; 28(4): 956-962. doi: 10.2337/diacare.28.4.956
Ewing DJ, Campbell IW, Clarke BF. Assessment of cardio-vascular effects in diabetic autonomic neuropathy and prognos-tic implications. Annals of Internal Medicine. 1992; (2): 308- 311. doi: 10.7326/0003-4819-92-2-308
Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007; 115(3): 387-397. doi: 10.1161/ CIRCULATIONAHA.106.634949
May O, Arildsen H. Assessing cardiovascular autonomic neu-ropathy in diabetes mellitus: how many tests to use? J Diabetes Complications. 2000; 14: 7-12. doi: http://dx.doi.org/10.1016/ s1056-8727(00)00062-3
Nazar K, Taton J, Chwalbinska-Moneta J, Brzezinska Z. Adrenergic responses to sustained handgrip in patients with juvenile-onset-type diabetes mellitus. Clin Sci Mol Med. 1975; 49(1): 39-44.
Ewing DJ, Kerr F, Leggett R, Murray A. Interaction between cardiovascular responses to sustained handgrip and Valsalva ma-noeuvre. British Heart Journal. 1976; 38: 483-490. doi: 10.1136/ hrt.38.5.483
Marin-Neto JA, Maciel BC, Gallo Júnior L, Junqueira Júnior LF, Amorim DS. Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas’s heart disease. British Heart Journal. 1986; 55(2): 204-210.
Hanson P, Nagle F. Isometric exercise: cardiovascular re-sponses in normal and cardiac populations. Cardiol Clin. 1987; 5: 157-170.
Rivera Farina PV, Pérez Turiel P, Herreros López A. Apli-cación de la Transformada Wavelet para el desarrollo de un método computacionalmente simple de detección del final de la onda T. IV Latin American Congress on Biomedical Engineer-ing 2007, Bioengineering Solutions for Latin America Health. IFMBE Proceedings. 2008; 18(40): 171-174. doi: 10.1007/978- 3-540-74471-9_40
Rivera Farina PV, Laguna P, Martinez JP, Perez Turiel J, Her-reros López A, Wong S. An alternative decision rule for thresh-old based t-wave measurement algorithms based on second de-rivative extrema. Computers in Cardiology. 2008; 709-712. doi: 10.1109/CIC.2008.4749140
Almeida R, Martinez JP, Rocha AP, Olmos S, Laguna P. Improved QT variability quantification by multilead automat-ic delineation. Computers in Cardiology. 2005; 503-506. doi: 10.1109/CIC.2005.1588148
Bedmar M, Harrigan E, Anciano R, Camm A, Rushkin J. The QT interval. Progress in Cardiovasc Dis. 2001; 43: 1-45.
Luo KR, Chao CC, Hsieh PC, Lue JH, Hsieh ST. Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care. 2012; 35(3): 612-616. doi: 10.2337/dc11-1607
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
